Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-CPN with Alcohol in Pancreatic Cancer
NCT00578279Phase 4Completed
- Sponsor
- Indiana University
- Start
- Mar 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ethanol in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by Indiana University. Primary endpoint: Change in Mean Pain Scale Rating at 1 year. Started Mar 2007; status: completed.
02
Drugs
ethanol
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00578279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578279.